IL1B and colorectal carcinoma: Moreover, compared to the CRC group, L‐tianma, M‐tianma, H‐tianma, or 5‐Fu treatments reduced TNF‐α, IL‐1β and IL‐6 levels, and increased IFN‐γ levels (Figure 2D–G).